Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 14Sarcoma 9Lymphoid 6Gastrointestinal 4Other hematologic neoplasm 3Plasma cell 1Head & Neck 1Dermatologic 1Breast 1

Conditions

Melanoma 791Carcinoma, Non-Small-Cell Lung 171Skin Neoplasms 154Neoplasms 107Neoplasm Metastasis 100Colorectal Neoplasms 96Carcinoma, Renal Cell 96Uveal Melanoma 92Breast Neoplasms 88Squamous Cell Carcinoma of Head and Neck 85Carcinoma, Basal Cell 85Lung Neoplasms 80Ovarian Neoplasms 79Lymphoma, T-Cell, Cutaneous 67Carcinoma, Merkel Cell 67Sarcoma 66Pancreatic Neoplasms 59Stomach Neoplasms 58Head and Neck Neoplasms 55Carcinoma, Hepatocellular 54Uterine Cervical Neoplasms 53Urinary Bladder Neoplasms 50Triple Negative Breast Neoplasms 44Esophageal Neoplasms 44Prostatic Neoplasms 43Endometrial Neoplasms 42Carcinoma, Squamous Cell 39Brain Neoplasms 39Carcinoma, Transitional Cell 37Lymphoma 34

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Acquired Immunodeficiency Syndrome × Dermatologic × 1 year × Clear all
NCT02479698 2026-05-20

Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus

M.D. Anderson Cancer Center

Phase 2 Recruiting
100 enrolled
Dermatologic

Acquired Immunodeficiency Syndrome, Neoplasms, Carcinoma, Merkel Cell, Encephalitis, Viral

Data powered by HemOnc (CC BY 4.0) Colophon âš¡